HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

elsibucol

structure in first source

Also Known As:

(4,2,6-di-tert-butyl-4-(1-(3,5-di-tert-butyl-4-hydroxy-phenylsulfanyl)-1-methyl-ethylsulfanyl)-phenoxy-butyric acid); AGI-1096

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        elsibucol: 2
- Carboxylic Acids: 973
  - Acyclic Acids
    - Butyrates: 2613
      - elsibucol: 2
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Butyrates: 2613
      - elsibucol: 2

Experts

1.	Desjarlais, Michel: 1 article (11/2014)
2.	Dhahri, Wahiba: 1 article (11/2014)
3.	Dussault, Sylvie: 1 article (11/2014)
4.	Mathieu, Raphael: 1 article (11/2014)
5.	Rivard, Alain: 1 article (11/2014)
6.	Balsam, Leora B: 1 article (05/2004)
7.	Coleman, Caroline: 1 article (05/2004)
8.	Hammainen, Pekka: 1 article (05/2004)
9.	Howard, Randy: 1 article (05/2004)
10.	Lijkwan, Maarten A: 1 article (05/2004)

Related Diseases

1.	Arteriosclerosis 05/27/2004 - "This is the first study to show that treatment of allograft recipients with AGI-1096 decreases the incidence of transplant arteriosclerosis. " 05/27/2004 - "Given these antioxidant, anti-inflammatory and antiproliferative properties, we reasoned that AGI-1096 may be able to prevent chronic allograft arteriosclerosis. " 05/27/2004 - "Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis."
2.	Atherosclerosis 11/01/2014 - "In hypercholesterolemic animals, elsibucol inhibits atherosclerosis and preserves endothelial healing following arterial injury. " 11/01/2014 - "Here we investigated the effect of elsibucol on the development of atherosclerosis following arterial injury in hypercholesterolemic rabbits. " 11/01/2014 - "Elsibucol inhibits atherosclerosis following arterial injury: multifunctional effects on cholesterol levels, oxidative stress and inflammation."
3.	Inflammation (Inflammations) 11/01/2014 - "Elsibucol inhibits atherosclerosis following arterial injury: multifunctional effects on cholesterol levels, oxidative stress and inflammation."
4.	Hypersensitivity (Allergy) 05/27/2004 - "In vivo, AGI-1096 demonstrated anti-inflammatory properties in a murine delayed-type hypersensitivity model. "
5.	Hyperplasia 11/01/2014 - "Despite its potent effect on neointimal hyperplasia, elsibucol does not prevent endothelial healing (Evans blue staining) following arterial injury. "

Related Drugs and Biologics

1.	Evans Blue (Blue, Evans)
2.	Cholesterol
3.	Antioxidants